Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELAGOLIX vs ELETRIPTAN HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELAGOLIX vs ELETRIPTAN HYDROBROMIDE: Safety Overview

Metric ELAGOLIX ELETRIPTAN HYDROBROMIDE
Total FAERS Reports 3,582 2,158
Deaths Reported 5 12
Death Rate 0.1% 0.6%
Hospitalizations 299 271
Average Patient Age 34.6 yrs 52.6 yrs
% Female Patients 99.7% 86.2%
FDA Approval Date Jul 23, 2018 Aug 11, 2017
Manufacturer AbbVie Inc. Zydus Pharmaceuticals USA Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription